|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.7 TWD | -1.59% |
|
-1.59% | -9.36% |
NatureWise Biotech & Medicals Corporation reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 228.59 million compared to TWD 249.8 million a year ago. Net income was TWD 30.02 million compared to TWD 30.81 million a year ago.
Basic earnings per share from continuing operations was TWD 0.61 compared to TWD 0.63 a year ago. Diluted earnings per share from continuing operations was TWD 0.61 compared to TWD 0.62 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -9.36% | 37.71M | |
| +19.98% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +14.32% | 13.79B | |
| +44.72% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B |
NATUREWISE BIOTECH & MEDICALS CORPORATION 
